Pharmamarketeer
overig

BRCA gene mutation found not to impact survival

15 januari 2018
Pharmafile

The BRCA1 and BRCA2 genes are known to significantly increase the chances of a woman developing cancer and it was assumed that the disease in these women would be more aggressive; research from the University of Southampton has contradicted this judgement, finding that there is no different in survival rates between women with breast cancer with or without the BRCA mutations.

Reageer

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)